Back to Search Start Over

Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129

Authors :
Clarissa Pedrosa da Costa Gomes
Bence Ágg
Andrejaana Andova
Serdal Arslan
Andrew Baker
Monika Barteková
Dimitris Beis
Fay Betsou
Stephanie Bezzina Wettinger
Branko Bugarski
Gianluigi Condorelli
Gustavo José Justo da Silva
Sabrina Danilin
David de Gonzalo-Calvo
Alfonso Buil
Maria Carmo-Fonseca
Francisco J. Enguita
Kyriacos Felekkis
Peter Ferdinandy
Mariann Gyöngyösi
Matthias Hackl
Kanita Karaduzovic-Hadziabdic
Jan Hellemans
Stephane Heymans
Markéta Hlavackova
Morten Andre Hoydal
Aleksandra Jankovic
Amela Jusic
Dimitris Kardassis
Risto Kerkelä
Gabriela M. Kuster
Päivi Lakkisto
Przemyslaw Leszek
Mitja Lustrek
Lars Maegdefessel
Fabio Martelli
Susana Novella
Timothy O’Brien
Christos Papaneophytou
Thierry Pedrazzini
Florence Pinet
Octavian Popescu
Ines Potočnjak
Emma Robinson
Shlomo Sasson
Markus Scholz
Maya Simionescu
Monika Stoll
Zoltan V. Varga
Manlio Vinciguerra
Angela Xuereb
Mehmet Birhan Yilmaz
Costanza Emanueli
Yvan Devaux
Source :
Non-Coding RNA, Vol 5, Iss 2, p 31 (2019)
Publication Year :
2019
Publisher :
MDPI AG, 2019.

Abstract

Cardiovascular disease (CVD) remains the leading cause of death worldwide and, despite continuous advances, better diagnostic and prognostic tools, as well as therapy, are needed. The human transcriptome, which is the set of all RNA produced in a cell, is much more complex than previously thought and the lack of dialogue between researchers and industrials and consensus on guidelines to generate data make it harder to compare and reproduce results. This European Cooperation in Science and Technology (COST) Action aims to accelerate the understanding of transcriptomics in CVD and further the translation of experimental data into usable applications to improve personalized medicine in this field by creating an interdisciplinary network. It aims to provide opportunities for collaboration between stakeholders from complementary backgrounds, allowing the functions of different RNAs and their interactions to be more rapidly deciphered in the cardiovascular context for translation into the clinic, thus fostering personalized medicine and meeting a current public health challenge. Thus, this Action will advance studies on cardiovascular transcriptomics, generate innovative projects, and consolidate the leadership of European research groups in the field. COST (European Cooperation in Science and Technology) is a funding organization for research and innovation networks (www.cost.eu).

Details

Language :
English
ISSN :
2311553X
Volume :
5
Issue :
2
Database :
Directory of Open Access Journals
Journal :
Non-Coding RNA
Publication Type :
Academic Journal
Accession number :
edsdoj.563c4538fbfa4167926b9769831be9f5
Document Type :
article
Full Text :
https://doi.org/10.3390/ncrna5020031